Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Maryna, Gorelik"'
Autor:
Nawneet Mishra, Joan Teyra, RuthMabel Boytz, Shane Miersch, Trudy N. Merritt, Lia Cardarelli, Maryna Gorelik, Filip Mihalic, Per Jemth, Robert A. Davey, Sachdev S. Sidhu, Daisy W. Leung, Gaya K. Amarasinghe
Publikováno v:
Data in Brief, Vol 43, Iss , Pp 108415- (2022)
SARS-CoV-2 pandemic opens up the curiosity of understanding the coronavirus. This demand for the development of the regent, which can be used for academic and therapeutic applications. The present data provide the biochemical characterization of synt
Externí odkaz:
https://doaj.org/article/a822c6ddef5d40eb9aa0c6caef9c9b2d
Autor:
Leonie Enderle, Karim H. Shalaby, Maryna Gorelik, Alexander Weiss, Levi L. Blazer, Marcin Paduch, Lia Cardarelli, Anthony Kossiakoff, Jarrett J. Adams, Sachdev S. Sidhu
Publikováno v:
mAbs, Vol 13, Iss 1 (2021)
In order to direct T cells to specific features of solid cancer cells, we engineered a bispecific antibody format, named Dual Antigen T cell Engager (DATE), by fusing a single-chain variable fragment targeting CD3 to a tumor-targeting antigen-binding
Externí odkaz:
https://doaj.org/article/777c600eb1a04893b2cef9f6918ac3c1
Autor:
Sheila K. Singh, Sachdev Sidhu, Jason Moffat, David Kaplan, Johan Nilvebrant, Naresh K. Murty, Kevin R. Brown, Natalie Grinshtein, David Bobrowski, Alexander Gont, Max London, Chirayu Chokshi, Jiahe Yang, Neil Savage, Minomi K. Subapanditha, Maryna Gorelik, Amy Hu, Mohini Singh, Jarrett Adams, Chitra Venugopal, Parvez Vora, Maleeha A. Qazi
Glioblastoma (GBM) carries a dismal prognosis and inevitably relapses despite aggressive therapy. Many members of the Eph receptor tyrosine kinase (EphR) family are expressed by GBM stem cells (GSC), which have been implicated in resistance to GBM th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5839f426a7976b2e29484db2fef4779e
https://doi.org/10.1158/0008-5472.c.6512080
https://doi.org/10.1158/0008-5472.c.6512080
Autor:
Sheila K. Singh, Sachdev Sidhu, Jason Moffat, David Kaplan, Johan Nilvebrant, Naresh K. Murty, Kevin R. Brown, Natalie Grinshtein, David Bobrowski, Alexander Gont, Max London, Chirayu Chokshi, Jiahe Yang, Neil Savage, Minomi K. Subapanditha, Maryna Gorelik, Amy Hu, Mohini Singh, Jarrett Adams, Chitra Venugopal, Parvez Vora, Maleeha A. Qazi
Protein expression of EphA2, EphA3, CD133, CD15, Bmi1, Sox2, FoxG1 and ITGA6 in GBM.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1935ad29429eaf1a3ae77b3efbd606
https://doi.org/10.1158/0008-5472.22425589.v1
https://doi.org/10.1158/0008-5472.22425589.v1
Autor:
Sheila K. Singh, Sachdev Sidhu, Jason Moffat, David Kaplan, Johan Nilvebrant, Naresh K. Murty, Kevin R. Brown, Natalie Grinshtein, David Bobrowski, Alexander Gont, Max London, Chirayu Chokshi, Jiahe Yang, Neil Savage, Minomi K. Subapanditha, Maryna Gorelik, Amy Hu, Mohini Singh, Jarrett Adams, Chitra Venugopal, Parvez Vora, Maleeha A. Qazi
Patient demographics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09041ba6988404cf92d42f31f4f80762
https://doi.org/10.1158/0008-5472.22425562.v1
https://doi.org/10.1158/0008-5472.22425562.v1
Autor:
Kamal Mandal, Gianina Wicaksono, Clinton Yu, Jarrett J. Adams, Michael R. Hoopmann, William C. Temple, Bonell Patiño Escobar, Maryna Gorelik, Christian H. Ihling, Matthew A. Nix, Akul Naik, Emilio Ramos, Corynn Kasap, Veronica Steri, Juan Antonio Camara Serrano, Fernando Salangsang, Paul Phojanakong, Melanie McMillan, Victor Gavallos, Andrew D. Leavitt, Andrea Sinz, Benjamin J. Huang, Elliot Stieglitz, Catherine C. Smith, Robert L. Moritz, Sachdeva S. Sidhu, Lan Huang, Arun P. Wiita
Safely expanding indications for cellular therapies has been challenging given a lack of highly cancer-specific surface markers. Here, we explore the hypothesis that tumor cells express cancer-specific surface protein conformations, invisible to stan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae2b772f0663a4c42355cf2c0c07b9b
https://doi.org/10.1101/2022.10.10.511511
https://doi.org/10.1101/2022.10.10.511511
Autor:
Kamal Mandal, Gianina Wicaksono, Clinton Yu, Jarrett J Adams, Michael R Hoopmann, William C Temple, Bonell Patino Escobar, Maryna Gorelik, Christian Ihling, Matthew A Nix, Akul Naik, Emilio Ramos, Corynn Kasap, Veronica Steri, Juan Antonio Camara Serrano, Fernando Salangsang, Paul Phojanakong, Melanie McMillan, Victor Gavallos, Andrew D Leavitt, Andrea Sinz, Benjamin J. Huang, Elliot Stieglitz, Catherine Smith, Robert L Moritz, Sachdeva S Sidhu, Lan Huang, Arun P Wiita
Publikováno v:
Blood. 140:867-868
Autor:
Chiara, Nardin, Abraham, Tettey-Matey, Viola, Donati, Daniela, Marazziti, Chiara, Di Pietro, Chiara, Peres, Marcello, Raspa, Francesco, Zonta, Guang, Yang, Maryna, Gorelik, Serena, Singh, Lia, Cardarelli, Sachdev S, Sidhu, Fabio, Mammano
Publikováno v:
International journal of molecular sciences. 23(13)
Connexin (Cx) hemichannels (HCs) are large pore hexameric structures that allow the exchange of ions, metabolites and a variety of other molecules between the cell cytoplasm and extracellular milieu. HC inhibitors are attracting growing interest as d
Autor:
Nawneet Mishra, Joan Teyra, RuthMabel Boytz, Shane Miersch, Trudy N. Merritt, Lia Cardarelli, Maryna Gorelik, Filip Mihalic, Per Jemth, Robert A. Davey, Sachdev S. Sidhu, Daisy W. Leung, Gaya K. Amarasinghe
Publikováno v:
Journal of molecular biology. 434(10)
The COVID-19 pandemic caused by SARS-CoV-2 infection has impacted the world economy and healthcare infrastructure. Key reagents with high specificity to SARS-CoV-2 proteins are currently lacking, which limits our ability to understand the pathophysio
Autor:
Maryna Gorelik, Alexander Weiss, Jarrett Adams, Sachdev S. Sidhu, Anthony A. Kossiakoff, Marcin Paduch, Lia Cardarelli, Karim H. Shalaby, Leonie Enderle, Levi L. Blazer
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
In order to direct T cells to specific features of solid cancer cells, we engineered a bispecific antibody format, named Dual Antigen T cell Engager (DATE), by fusing a single-chain variable fragment targeting CD3 to a tumor-targeting antigen-binding